Quick Summary:
In the rapidly evolving field of healthcare, the global interventional cardiology devices market is showing signs of significant growth. With a broad range of products included, from angioplasty balloons to catheters, these devices are indispensable tools for a great variety of cardiovascular treatments. Moreover, their use is expanding, driven not only by the increasing prevalence of conditions such as diabetes and hypertension, but also by the global rise in the geriatric population.
Innovation is a key factor fueling growth in this market, with the introduction of novel items such as bioabsorbable stents and advanced imaging solutions that cater to timely diagnosis and effective treatment of cardiovascular ailments. The healthcare sector's broadening capabilities, combined with significant developments in medical infrastructure worldwide, are further driving demand. In purchasing this comprehensive market research report, you will gain valuable insights into the trends, forecasts, and competitive landscape of the interventional cardiology devices market.
The global interventional cardiology devices market size reached US$ 21.3 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 33.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028.
Interventional cardiology devices refer to the medical equipment and guiding tools used for performing cardiovascular procedures, such as angioplasty and stenting. Some of the commonly used devices include angioplasty balloons, stents, mitral, pulmonary and tricuspid valves, catheters, plaque modification and hemodynamic flow alteration devices. Along with this, guidewires, vascular closure and hemostasis devices and introducer sheaths are also utilized. These tools and devices are widely used for medical procedures, such as coronary artery bypass grafting (CABG), trans-myocardial laser revascularization (TMR), arrhythmia treatment, aneurysm repair, open-heart, off-pump heart and minimally invasive (MI) heart surgeries. They are also used for other procedures, such as atherectomy, embolic protection and percutaneous valve repair.
2. What is the expected growth rate of the global interventional cardiology devices market during 2023-2028?
3. What are the key factors driving the global interventional cardiology devices market?
4. What has been the impact of COVID-19 on the global interventional cardiology devices market?
5. What is the breakup of the global interventional cardiology devices market based on the product?
6. What is the breakup of the global interventional cardiology devices market based on the end user?
7. What are the key regions in the global interventional cardiology devices market?
8. Who are the key players/companies in the global interventional cardiology devices market?
Interventional cardiology devices refer to the medical equipment and guiding tools used for performing cardiovascular procedures, such as angioplasty and stenting. Some of the commonly used devices include angioplasty balloons, stents, mitral, pulmonary and tricuspid valves, catheters, plaque modification and hemodynamic flow alteration devices. Along with this, guidewires, vascular closure and hemostasis devices and introducer sheaths are also utilized. These tools and devices are widely used for medical procedures, such as coronary artery bypass grafting (CABG), trans-myocardial laser revascularization (TMR), arrhythmia treatment, aneurysm repair, open-heart, off-pump heart and minimally invasive (MI) heart surgeries. They are also used for other procedures, such as atherectomy, embolic protection and percutaneous valve repair.
Interventional Cardiology Devices Market Trends:
The increasing prevalence of diabetes, hypertension and cardiovascular disorders, such as coronary artery disease (CAD, is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Interventional cardiology and embolic protection devices are widely used to capture embolic debris to ensure continuous blood flow and preventing blockages. Additionally, the development of innovative bioabsorbable and drug-eluting stents, pacemakers and drug-coated mesh tubes is acting as another growth-inducing factor. In line with this, the increasing utilization of advanced imaging solutions, such as intravenous ultrasound (IVUS), fractional flow reserve (FFR) and optical coherence tomography (OCT) for early diagnosis and timely treatment of cardiovascular ailments, is also contributing to the growth of the market. Other factors, including rising healthcare expenditure capacities of the masses, along with extensive improvements in the medical infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global interventional cardiology devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and end user.Breakup by Product:
- Stents
- Drug Eluting Stents
- Bare Metal Stents
- Bio-Absorbable Stents
- Interventional Catheters
- IVUS Catheters
- Guiding Catheters
- Angiography Catheters
- PTCA Guidewires
- Balloon Inflation Device
- PTCA Balloons
- Cutting Balloons
- Scoring Balloons
- Drug Eluting Balloons
- Normal Balloons
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Alvimedica, B. Braun Melsungen AG, Biosensors International Group Ltd. (Bluesail Medical Co. Ltd.), BIOTRONIK Inc., Boston Scientific Corporation, Cook Group Incorporated, ENDOCOR GmbH, Koninklijke Philips N.V., Medinol Ltd., Medtronic plc and Terumo Corporation.Key Questions Answered in This Report
1. What was the size of the global interventional cardiology devices market in 2022?2. What is the expected growth rate of the global interventional cardiology devices market during 2023-2028?
3. What are the key factors driving the global interventional cardiology devices market?
4. What has been the impact of COVID-19 on the global interventional cardiology devices market?
5. What is the breakup of the global interventional cardiology devices market based on the product?
6. What is the breakup of the global interventional cardiology devices market based on the end user?
7. What are the key regions in the global interventional cardiology devices market?
8. Who are the key players/companies in the global interventional cardiology devices market?
Frequently Asked Questions about the Global Interventional Cardiology Devices Market
What is the estimated value of the Global Interventional Cardiology Devices Market?
What is the growth rate of the Global Interventional Cardiology Devices Market?
What is the forecasted size of the Global Interventional Cardiology Devices Market?
Who are the key companies in the Global Interventional Cardiology Devices Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | July 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 21.3 Billion |
| Forecasted Market Value ( USD | $ 33.8 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
Table of Contents
1 Preface3 Executive Summary10 Value Chain Analysis12 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Interventional Cardiology Devices Market
6 Market Breakup by Product
7 Market Breakup by End User
8 Market Breakup by Region
9 SWOT Analysis
11 Porters Five Forces Analysis
13 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- Alvimedica
- B. Braun Melsungen AG
- Biosensors International Group Ltd. (Bluesail Medical Co. Ltd.)
- BIOTRONIK Inc.
- Boston Scientific Corporation
- Cook Group Incorporated
- ENDOCOR GmbH
- Koninklijke Philips N.V.
- Medinol Ltd.
- Medtronic plc
- Terumo Corporation.
Methodology
LOADING...
